Lindsay Rhodes is an Ophthalmology physician affiliated with University of Alabama at Birmingham. OpenAlex indexes 44 publications with 611 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alcon Vision LLCProgram year202519 payments
- ABBVIE INC.Program year20256 payments
- Johnson & Johnson Surgical Vision, Inc.Program year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
81.5%Prostaglandin Analog27.9%Latanoprost94%Lumigan6%Part D≥206 patientsCorticosteroid16.7%Prednisolone Acetate100%Part D≥269 patients+ 4 more classes in this area
Musculoskeletal
11.5%Cyclooxygenase Inhibitor11.5%Ketorolac Tromethamine100%Part D≥180 patientsCardiovascular
3.6%Beta blocker3.6%Timolol Maleate100%Part D≥36 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2016–2022 per NIH RePORTER. The latest:
- Using Telemedicine to Prevent Blindness in an At-Risk Rural Alabama Population
University of Alabama at Birmingham
FY2022$700,000U01DP006441 - Using Telemedicine to Prevent Blindness in an At-Risk Rural Alabama Population
University of Alabama at Birmingham
FY2021$699,999U01DP006441 - Using Telemedicine to Prevent Blindness in an At-Risk Rural Alabama Population
University of Alabama at Birmingham
FY2020$699,999U01DP006441
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Suzanne Oparil, MD
University of Alabama at Birmingham
Richard Whitley, MD
University of Alabama at Birmingham
David Standaert, MD, PhD
University of Alabama at Birmingham
Bruce Korf, MD
University of Alabama at Birmingham
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”